ArticleMolecular biology and evolution2026
Bacterial Persistence Modulates the Speed, Magnitude, and Onset of Antibiotic Resistance Evolution.
Article in Molecular biology and evolution, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Bacterial persistence, a phenomenon where a subpopulation of cells can exhibit increased survival to antibiotic stress, allows part of the population to withstand antibiotic treatment. This can have far-reaching implications for the evolution of antibiotic resistance, yet its evolutionary consequences remain insufficiently understood. Here, using a combination of evolutionary modeling and experimental evolution data on Escherichia coli, we show that persistence impacts the speed, onset, and magnitude of antibiotic resistance evolution. Specifically, high persistence facilitates the slow establishment of small-effect mutations by protecting them from antibiotic killing, while low persistence boosts the rapid yet unpredictable emergence of rare large-effect resistance mutations by amplifying their competitive advantage. Our results show that persistence level has a critical impact on the trade-off between short-term population survival and the evolution of high-level resistance, with distinct outcomes depending on the severity of the antibiotic treatment regimen. These findings provide key insights for designing antibiotic treatment strategies that minimize the risk of antibiotic resistance evolution while maintaining treatment efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.